(Q37976320)

English

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

scientific article published on 15 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial (English)

1 reference

Europe PubMed Central

26 August 2017

0 references

0 references

oligodendroglioma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andreas von Deimling

7

object named as

Andreas von Deimling

0 references

Pieter Wesseling

19

object named as

Pieter Wesseling

1 reference

Europe PubMed Central

26 August 2017

object named as

Pierre Bady

12

0 references

object named as

Monika E Hegi

1

0 references

National Cancer Institute of Canada Clinical Trials Group

21

object named as

National Cancer Institute of Canada Clinical Trials Group

1 reference

Europe PubMed Central

26 August 2017

13

object named as

Michael Weller

1 reference

Europe PubMed Central

26 August 2017

author name string

Robert-Charles Janzer

2

1 reference

Europe PubMed Central

26 August 2017

Wanyu L Lambiv

3

1 reference

Europe PubMed Central

26 August 2017

Thierry Gorlia

4

1 reference

Europe PubMed Central

26 August 2017

Mathilde C M Kouwenhoven

5

1 reference

Europe PubMed Central

26 August 2017

Christian Hartmann

6

1 reference

Europe PubMed Central

26 August 2017

Danielle Martinet

8

1 reference

Europe PubMed Central

26 August 2017

Nathalie Besuchet Schmutz

9

1 reference

Europe PubMed Central

26 August 2017

Annie-Claire Diserens

10

1 reference

Europe PubMed Central

26 August 2017

Marie-France Hamou

11

1 reference

Europe PubMed Central

26 August 2017

Martin J van den Bent

14

1 reference

Europe PubMed Central

26 August 2017

Warren P Mason

15

1 reference

Europe PubMed Central

26 August 2017

René-Olivier Mirimanoff

16

1 reference

Europe PubMed Central

26 August 2017

Roger Stupp

17

1 reference

Europe PubMed Central

26 August 2017

Karima Mokhtari

18

1 reference

Europe PubMed Central

26 August 2017

European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups

20

1 reference

Europe PubMed Central

26 August 2017

publication date

15 January 2012

1 reference

Europe PubMed Central

26 August 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

26 August 2017

123

1 reference

Europe PubMed Central

26 August 2017

6

1 reference

Europe PubMed Central

26 August 2017

841-852

1 reference

Europe PubMed Central

26 August 2017

https://scigraph.springernature.com/pub.10.1007/s00401-011-0938-4

0 references

Analysis of the IDH1 codon 132 mutation in brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Correlation among pathology, genotype, and patient outcomes in glioblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

To infinium, and beyond!

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Genetic profile of astrocytic and oligodendroglial gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Metabolism unhinged: IDH mutations in cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

MGMT promoter methylation in malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0938-4

21 January 2018

Identifiers

10.1007/S00401-011-0938-4

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37976320&oldid=1735776577"